← Back to Clinical Trials
Recruiting NCT07223086

NCT07223086 Use of Tinted Contact Lenses for Concussion-Related Light Sensitivity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07223086
Status Recruiting
Phase
Sponsor University of Alabama at Birmingham
Condition Concussion, Mild
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-05-08
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Narrow band (tinted) contact lensesbroad band (clear) contact lenses

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-05-08 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to gather pilot data on the effectiveness of daily disposable tinted contact lenses in reducing photophobia (light sensitivity) following a concussion, with the goal of facilitating the return to work or school.

Eligibility Criteria

Inclusion Criteria: * diagnosed mild traumatic brain injury (concussion) * age 18 or older * Within 24 months of initial injury * experiencing symptoms of photophobia (light sensitivity), increased photophobia since the injury, or no symptoms of photophobia Exclusion Criteria: * moderate or severe concussion * active infection or inflammation that contradicts the use of soft contact lenses * subjects unable to safely perform insertion and removal of the contact lenses

Contact & Investigator

Central Contact

Candice I Turner, OD

✉ citurner@uab.edu

📞 (205)934-0997

Principal Investigator

Candice I Turner, OD

PRINCIPAL INVESTIGATOR

University of Alabama at Birmingham School of Optometry

Frequently Asked Questions

Who can join the NCT07223086 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Concussion, Mild. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07223086 currently recruiting?

Yes, NCT07223086 is actively recruiting participants. Contact the research team at citurner@uab.edu for enrollment information.

Where is the NCT07223086 trial being conducted?

This trial is being conducted at Birmingham, United States.

Who is sponsoring the NCT07223086 clinical trial?

NCT07223086 is sponsored by University of Alabama at Birmingham. The principal investigator is Candice I Turner, OD at University of Alabama at Birmingham School of Optometry. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology